ALZN002 Investigational cell-based vaccine designed to stimulate immune clearance of Alzheimer’s amyloid; its clinical program was paused, with resumption planned.
Visit productCosigns Received
Be the first Cosign
Put your name behind ALZN002.
Add it to your Products I use list and share why you use it.